Seok-Ho Lee
Radiation Oncology Seok-Ho Lee Favorite Doctor
  • SpecialtyHead and Neck cancer, Colorectal cancer, anal cancer, Sarcoma, Skin cancer
  • Site
Appointment
Schedule
의료진 진료일정
Week M T W T F S
AM         Present  
PM   Present     Present  
Clinical Interests

Colon cancer
Rectal cancer
Anal cancer
Head and neck cancer

Soft tissue sarcoma
Skin cancer
Benign (thyroid opthalmopathy)

Education
Education
Gachon University Graduate College of Medicine, Ph.D
Inha University Graduate School of Medicine, MS
Inha University School of Medicine, MD
The Cyber University of Korea
Career
Career
2017~Present Gachon University Gil Medical Center, Professor
2011~2017 Gachon University Gil Medical Center, Associate Professor
2007~2011 Gachon University Gil Medical Center, Assistant Professor
2005~2007 Gachon University Gil Medical Center, Fellow
2003~2005 National Cancer Center, Proton Therapy Center
2004 The first author of the Best Paper on Korean Radiation Oncology
2010 Best Poster Award of The Korean Association of Hepato-biliary-Pancreatic Surgery
2012 JSMO (Japanese Society of Medical Oncology) Travel Award
2014 JSMO (Japanese Society of Medical Oncology) Travel Award
2016 ESMO Asia, KACO Travel Grant
2018 ~2020 Marquis Who's Who in the World
2018 Albert Nelson Marquis Lifetime Achievement Award
More
Community
Community
Member of The Korean Society for Radiation Oncology , KOSRO
Member of The European Society for Radiotherapy and Oncology, ESTRO
Member of The Korean Society of Medical Oncology, KSMO
Member of The Korean Radiosurgery Society
More
Training
Training
2010.5.17 -2010.5.20 BRAINLAB education (Treatment PlanningnbspandnbspPhysics), Germany
2019.09-2020.08 Maastricht University Hospital, Netherlands, Visiting Researcher
License
License
Radiation Oncology Specialist
Medical License
Geriatric Diseases Accreditation
Bachelor of Information Science
Seok-Ho Lee
Paper
Paper
2021 Biche Osong, Ilknur Sanli, Paul C. Willems, Leonard Wee, Andre Dekker, Seok Ho Lee, Johan van Soest. Overall survival nomogram for patients with spinal bone metastases (SBM). Clin Transl Radiat Oncol. 2021 May; 28: 48–53. Published online 2021 Mar 11. doi: 10.1016/j.ctro.2021.02.010
2021 Cho WK, Park W, Kim YS, Kang HC, Kim JH, Kim KS, Choi KH, Chang SK, Ahn KJ, Lee SH, Kim S, Kim J, Eom KY, Lee J, Lee JH, Choi JH. Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03). Eur J Obstet Gynecol Reprod Biol . 2021 Mar;258:396-400. doi: 10.1016/j.ejogrb.2021.01.034. Epub 2021 Jan 22.
2020 Kim YJ, Kim YS, Shin JW, Osong B, Lee SH (correspondence). Prediction scor
2019 Lee JH, Lee SH (correspondence). Selecting the Appropriate Radiation Therapy Technique for Malignant Spinal Cord Compression Syndrome. Front Oncol. 2019; 9: 65. 
2018 Kim H, Kim YS, Joo JH, Eom KY, Park W, Kim JH, Lee JH, Kim YS, Lee SH, Ahn K, Kim YB, Lee MY, Chang SK. Tumor Boost Using External Beam Radiation in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy: Outcome From a Multicenter Retrospective Study (Korean Radiation Oncology Group 1419).Int J Gynecol Cancer. 2018 Feb;28(2):371-378.
2017 Kwon J, Eom KY, Kim YS, Park W, Chun M, Lee J, Kim YB, Yoon WS, Kim JH, Choi JH, Chang SK, Jeong BK, Lee SH, Cha J. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04). Cancer Res Treat.2017 Oct 24.doi: 10.4143/crt.2017.346
2017 Lee SW, Lee SH, Kim J, Kim YS, Yoon MS, Jeong S, Kim JH, Lee J, Eom KY, Jeong BK, Sung SY, Lee SJ, Lee JH.Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01. GynecolOncol. 2017 Nov;147(2):334-339.
2017 Jung J, Kim YS, Joo JH, Park W, Lee JH, Kim JH, Yoon WS, Lee SH, Eom KY, Kim YB. Oncologic Outcomes After Adjuvant Radiotherapy for Stage II Endometrial Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-10). Int J Gynecol Cancer. 2017 Sep;27(7):1387-1392.
2017 Ryu SH, Heo SH, Park EY, Choi KC, Ryu JW, Lee SH, Lee SW. Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-targeted Genes. Anticancer Res. 2017 Feb;37(2):607-614.
2017 Lee KC, Kim HJ, Sung K, Choi YE, Lee SH (correspondence), Lim S, Lee KB, Shin JW, Park CY, Kim YS, Sym SJ, Shim YS, Choi SJ. The Predictive Value of Tumor Size, Volume, and Markers During Radiation Therapy in Patients With Cervical Cancer. Int J Gynecol Cancer. 2017 Jan;27(1):123-130.
2017 Lim S, Lee SH, Lee KB, Park CY. The influence of number of high risk factors on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy and adjuvant chemoradiation.ObstetGynecol Sci. 2016 May;59(3):184-91. Anticancer Res. 2017 Feb;37(2):607-614
2016 Kang IG, Kim ST, Lee SH, Baek MK. Failed septal extension graft in a patient with a history of radiotherapy. MaxillofacPlastReconstr Surg. 2016 Oct 25;38(1):40.
2016 Lee SH, Kim HJ, Kim WC. Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer.Asia Pac J ClinOncol. 2016 Dec;12(4):388-395.
2015 Lee SH, Lee KC, Choi J, Ahn SH, Lee SH, Sung KH, Kil SH. Clinical applicability of biologically effective dose calculation for spinal cord in fractionated spine stereotactic body radiation therapy. Radiol Oncol. 2015 Mar 25;49(2):185-91.
<Presentation>
2018 The Value of Hematologic Parameters for Predicting Tumor Response in Patients Receiving Radiotherapy for Cervical Cancer (The Korean Society for Radiation Oncology (KOSRO, poster presentation)
2017 Prognostic Role of Pretreatment Hematologic Parameters in Patients Receiving Definitive Radiotherapy for Cervical Cancer (KOSRO, poster presentation)
2016 The role of SUVmax in 18F-FDG PET/CT for assessing radiation therapy response for cervical cancer ( ESMO Asia 2016 Congress , poster presentation)
2015 The prognostic significance of tumor volume response and tumor marker changes during radiation therapy in cervical cancer patients (3rd international conference of federation of asian clinical oncology, Oral presentation)
2014 Assessment of tumor volume and serum tumor marker levels during chemoradiation therapy for cervix cancer (JSMO 2014, Poster)
2013 A Dosimetric Comparison of Radiotherapies for Paraaortic Lymph Node Metastasis (JSCO , poster presentation)
2013 Assessment of Tumor Volume Regression and Serum Squamous Cell Carcinoma Antigen during Chemoradiation Therapy for Cervical Cancer (KOSRO, poster presentation)
2012 Volumetric Intensity Modulated Arc Therapy for Primary Hepatocellular Carcinoma: comparison with 3-D Conformal Radiotherapy (The 10th Annual Meeting of Japanese Society of Medical Oncology, poster presentation)
2011 The Usefulness of Simple Shielding Technique using Multileaf Collimator in Breast Radiation Therapy (KOSRO, poster presentation)
2010 Analysis of the Outcomes of Adjuvant Radiation Therapy and the Prognostic Factors for Stage II/III Pancreatic Cancer (Annual Congress of the Korean Association of HBP Surgery, poster presentation)
2010 Results of Radiation Therapy with Chemotherapy for Patients with Cervical Cancer and Supraclavicular Lymph Node Involvement (The Korean Cancer Association, poster presentation)
More